| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Richard A. Zordani Jr. is Director at GALT. Richard A. Zordani Jr.'s net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $141K at current prices.
Our model assigns Richard A. Zordani Jr. a middling insider score of 52/100, based on 7 past trades. Over a 12-month horizon, 57.1% of those trades were profitable, with an average 12-month return of +18.9%.
Net of sales, the GALT filings show accumulation of 29,500 shares.
Richard A. Zordani Jr. has 12 Form 4 filings on record from March 2021 to January 2026, all as Director at Galectin Therapeutics (GALT), 2021–2026.
The 15 reported transactions were 8 open-market purchases and 7 option or other derivative awards.
Counted by filing, the open-market trades come to 6 purchases worth about $50K and no sales.
The largest open-market purchase was 5,000 shares of GALT at an average $2.50 on July 28, 2022, about $13K. Twelve months later GALT was down 40%.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 24, 2024 | GALT Galectin Therapeutics Inc | Director | Buy | 10,000 | $0.82 | $8,164.00 | +31.2% | +96.3% | +379.4% | |
| Aug 23, 2024 | GALT Galectin Therapeutics Inc | Director | Buy | 3,500 | $2.30 | $8,050.00 | +12.2% | +17.7% | +77.5% | |
| Apr 30, 2024 | GALT Galectin Therapeutics Inc | Director | Buy | 1,000 | $3.52 | $3,520.00 | New | -26.8% | -61.0% | |
| Jul 28, 2022 | GALT Galectin Therapeutics Inc | Director | Buy | 5,000 | $2.50 | $12,500.00 | +20.3% | -42.3% | -39.9% | |
| Apr 4, 2022 | GALT Galectin Therapeutics Inc | Director | Buy | 5,000 | $1.61 | $8,025.00 | +25.5% | -8.1% | +21.7% | |
| Jan 14, 2022 | GALT Galectin Therapeutics Inc | Director | Buy | 5,000 | $2.02 | $10,100.00 | +34.3% | -13.9% | -43.6% |